Straits Times Index
3,348.87 +12.28 (+0.37%) S&P 500
5,298.85 +21.34 (+0.40%) Dow
38,653.56 -32.76 (-0.08%) Nasdaq
16,894.27 +159.26 (+0.95%) Bitcoin USD
70,046.85 +2,027.70 (+2.98%) CMC Crypto 200
1,501.42 +33.49 (+2.28%)
Recordati Industria Chimica e Farmaceutica S.p.A. (REC.VI)
| Previous close | 47.48 |
| Open | 48.64 |
| Bid | 48.42 x 0 |
| Ask | 48.94 x 0 |
| Day's range | 48.64 - 48.64 |
| 52-week range | 41.95 - 53.20 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 10.234B |
| Beta (5Y monthly) | 0.36 |
| PE ratio (TTM) | 26.15 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.26 (2.65%) |
| Ex-dividend date | 17 May 2024 |
| 1y target est | N/A |
- Reuters
CVC explores options for Italy's Recordati, Bloomberg News reports
CVC and Recordati did not immediately respond to a Reuters request for comments. A CVC-led consortium of investment funds had agreed to buy 51.8% of Recordati in a deal worth about 3 billion euros in 2018. Shares of Recordati have risen about 7.7% since the beginning of this year, giving the company a market capitalization of about 11 billion euros ($11.77 billion).
- Reuters
UPDATE 1-CVC explores options for Italy's Recordati, Bloomberg News reports
CVC Capital Partners is exploring options for its controlling stake in Italian pharmaceutical group Recordati SpA, Bloomberg News reported on Tuesday, citing people familiar with the matter. CVC and Recordati did not immediately respond to a Reuters request for comments. A CVC-led consortium of investment funds had agreed to buy 51.8% of Recordati in a deal worth about 3 billion euros in 2018.
